Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000891293-10-000013)

Filing Details

Accession Number:: 0000891293-10-000013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-05-28 13:00:00
Reporting Period:: 2010-05-28

Filing Date:: 2010-05-28
Accepted Time:: 2010-05-28 18:48:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891293	Cell Therapeutics Inc	CTIC	Pharmaceutical Preparations (2834)	911533912

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1041084	Phd M Phillip Nudelman	501 Elliott Ave W, #400 Seattle WA 98119		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-05-28	2,800	$0.38	1,113,506	No	4	S	Direct
Common Stock	Disposition	2010-05-28	2,600	$0.38	1,110,906	No	4	S	Direct
Common Stock	Disposition	2010-05-28	5,800	$0.39	1,105,106	No	4	S	Direct
Common Stock	Disposition	2010-05-28	5,100	$0.39	1,100,006	No	4	S	Direct
Common Stock	Disposition	2010-05-28	13,400	$0.39	1,086,606	No	4	S	Direct
Common Stock	Disposition	2010-05-28	3,000	$0.39	1,083,606	No	4	S	Direct
Common Stock	Disposition	2010-05-28	4,000	$0.39	1,079,606	No	4	S	Direct
Common Stock	Disposition	2010-05-28	300	$0.39	1,079,306	No	4	S	Direct
Common Stock	Disposition	2010-05-28	100	$0.39	1,079,206	No	4	S	Direct
Common Stock	Disposition	2010-05-28	2,900	$0.40	1,076,306	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.